Literature DB >> 3160727

Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.

K K Hamilton, L J Fretto, D S Grierson, P A McKee.   

Abstract

von Willebrand factor (vWF), a multimeric protein that mediates platelet adhesion, circulates in association with the procoagulant Factor VIII (FVIII). In previous reports, plasmin was shown in vitro to inactivate FVIII and cleave the vWF subunit extensively, but to cause only a modest decrease in vWF platelet-agglutinating activity. In the present study, the digestion of vWF multimers by plasmin was analyzed by sodium dodecyl sulfate-agarose gel electrophoresis and radioimmunoblotting. In vitro, plasmin degraded the large vWF multimers to smaller forms that could be distinguished from the small multimers present before digestion only by a slightly increased electrophoretic mobility. These plasmin-cleaved "multimers" were composed of disulfide-linked fragments with no intact vWF subunits. Thus, many plasmin cleavages occur within disulfide loops. The slight increase in mobility of plasmin-digested vWF is in part explained by the early cleavage from the multimers of a 34,000-mol wt peptide, which was purified and partially sequenced. The amino-terminal sequence (33 residues) agrees with the previously reported sequence (15 residues) for the amino terminus of the intact vWF subunit. Analysis of plasmin-digested vWF allowed deduction of a model for the native vWF structure, including the approximate location of the interprotomer disulfide bond(s). To determine whether plasmin would digest vWF in vivo, plasmas from 12 patients and 2 normal volunteers who received intravenous streptokinase (SK) were analyzed. Rather than vWF digestion, a two- to threefold rise in vWF antigen and platelet-agglutinating activity occurred within 2 h after a single SK dose, and the increase was greatest among the largest multimers. In contrast, FVIII clotting activity dropped to 10-20% of pre-SK levels. Thus, although plasmin destroys FVIII, a pharmacologically induced fibrinolytic state is associated with significant release of vWF from endothelial cells, platelets, or some other storage pool.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160727      PMCID: PMC423761          DOI: 10.1172/JCI111956

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.

Authors:  M E Switzer; P A McKee
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

2.  In-vitro and in-vivo studies of a preparation of urokinase.

Authors:  G P MCNICOL; S B GALE; A S DOUGLAS
Journal:  Br Med J       Date:  1963-04-06

3.  Effects of enzymatic degradation on the subunit composition and biologic properties of human factor VIII.

Authors:  V Atichartakarn; V J Marder; E P Kirby; A Z Budzynski
Journal:  Blood       Date:  1978-02       Impact factor: 22.113

4.  Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein.

Authors:  J M Sodetz; S V Pizzo; P A McKee
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

5.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

6.  Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.

Authors:  R B Counts; S L Paskell; S K Elgee
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

7.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

8.  Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs.

Authors:  P M Mannucci; M Aberg; I M Nilsson; B Robertson
Journal:  Br J Haematol       Date:  1975-05       Impact factor: 6.998

9.  Localization of the alpha-chain cross-link acceptor sites of human fibrin.

Authors:  L J Fretto; E W Ferguson; H M Steinman; P A McKee
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

10.  In vivo and in vitro effects of thrombin and plasmin on human factor VIII (AHF).

Authors:  E C Lian; R L Nunez; D R Harkness
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

View more
  12 in total

1.  Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation.

Authors:  B A Herbig; S L Diamond
Journal:  J Thromb Haemost       Date:  2015-07-28       Impact factor: 5.824

Review 2.  Factor VIII/von Willebrand factor: a multivalent ligand binding to platelets and collagen.

Authors:  M Furlan
Journal:  Blut       Date:  1986-06

3.  A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.

Authors:  I Tornai; J Arnout; H Deckmyn; K Peerlinck; J Vermylen
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

4.  Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.

Authors:  J A Dent; S D Berkowitz; J Ware; C K Kasper; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 5.  The plasmin-antiplasmin system: structural and functional aspects.

Authors:  Johann Schaller; Simon S Gerber
Journal:  Cell Mol Life Sci       Date:  2010-12-07       Impact factor: 9.261

Review 6.  Coagulation disorders of cardiopulmonary bypass: a review.

Authors:  Domenico Paparella; Stephanie J Brister; Michael R Buchanan
Journal:  Intensive Care Med       Date:  2004-07-24       Impact factor: 17.440

7.  Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.

Authors:  S Layet; J P Girma; B Obert; E Peynaud-Debayle; N Bihoreau; D Meyer
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

8.  Substructure of human von Willebrand factor.

Authors:  W E Fowler; L J Fretto; K K Hamilton; H P Erickson; P A McKee
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

Authors:  T S Zimmerman; J A Dent; Z M Ruggeri; L H Nannini
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

10.  Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin.

Authors:  S D Berkowitz; J Dent; J Roberts; Y Fujimura; E F Plow; K Titani; Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.